New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
06:09 EDTQLTI, AUXLAxial enters voting agreement with Auxilium over QLT Inc.
Axial Capital disclosed that it entered into a voting agreement with Auxilium Pharmaceuticals (AUXL) agreeing to vote in favor of any transactions requiring shareholder vote arising out of a plan of merger entered into among QLT Inc. (QLTI) and Auxilium. Axial added that it has been and may continue to be in contact with members of QLT's management, board and others regarding alternatives that the company could employ to maximize shareholder value. Axial owns 17.35% of QLT's outstanding shares.
News For QLTI;AUXL From The Last 14 Days
Check below for free stories on QLTI;AUXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
06:41 EDTAUXLAuxilium reports XIAFLEX milestone, triggers $10M payment
Auxilium Pharmaceuticals announced that the company will receive a $10M regulatory milestone payment from its partner Asahi Kasei Pharma Corporation. The payment is due because of the successful submission of a regulatory application to the Japanese Pharmaceutical and Medical Device Agency, or PMDA, for XIAFLEX for the treatment of Dupuytren's contracture, or DC. The review by PMDA is expected to be completed by mid-2015. XIAFLEX is a biologic approved in the U.S., EU, Canada and Australia for the treatment of adult DC patients with a palpable cord and, in the U.S. for the treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use